Tirzepatide, meanwhile, is also approved for type 2 diabetes and has shown promising results in weight loss and obesity management
While cholecystitis is no longer a concern after gallbladder removal, patients should be aware that biliary complications such as bile duct stones (choledocholithiasis) can still occur, particularly during rapid weight loss
For a patient starting at 200 lbs, this translates to a weight loss of roughly 30 to 32 lbs
Both medications reduce appetite through different pathways, and their combined effect might lead to inadequate caloric and nutrient intake, potentially causing muscle loss, vitamin deficiencies, or metabolic complications
FDA Approval The U.S
The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system